Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease

Affiliations

¹ Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
² Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA.
³ Departments of Pediatrics and Biochemistry & Molecular Biology, Atlantic Research Centre, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
⁴ Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA. isacson@hms.harvard.edu.
⁵ Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA. phallett@mclean.harvard.edu.
⁶ Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK. frances.platt@pharm.ox.ac.uk.

Published Erratum

Mylene Huebecker et al. Mol Neurodegener. 2020.

. 2020 Jan 15;15(1):6.

doi: 10.1186/s13024-019-0355-z.

¹ Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
² Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA.
³ Departments of Pediatrics and Biochemistry & Molecular Biology, Atlantic Research Centre, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
⁴ Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA. isacson@hms.harvard.edu.
⁵ Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA. phallett@mclean.harvard.edu.
⁶ Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK. frances.platt@pharm.ox.ac.uk.

Abstract

The original article [1] contains an error in the y-axes of Fig. 8's sub-figures whereby 'CSF' is mistakenly mentioned instead of 'serum'.

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
Huebecker M, Moloney EB, van der Spoel AC, Priestman DA, Isacson O, Hallett PJ, Platt FM. Huebecker M, et al. Mol Neurodegener. 2019 Nov 8;14(1):40. doi: 10.1186/s13024-019-0339-z. Mol Neurodegener. 2019. PMID: 31703585 Free PMC article.

1. Huebecker M, Moloney ER, van der Spoel AC, Priestman DA, Isacson O, Hallett PJ, Platt FM. Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease. Mol Neurodegener. 2019;14:40. doi: 10.1186/s13024-019-0339-z. - DOI - PMC - PubMed